CSIMarket



Amgen Inc   (AMGN)
Other Ticker:  
 
 

AMGN's Revenue Growth by Quarter and Year

Amgen Inc 's Revenue results by quarter and year




AMGN Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 25,979.00 25,424.00 23,362.00
III Quarter September - - - -
II Quarter June - - - -
I Quarter March 0.00 - - -
FY   - 25,979.00 25,424.00 23,362.00



AMGN Revenue first quarter 2022 Y/Y Growth Comment
Amgen Inc in the first quarter 2022 recorded of $ 0.00 millions.

According to the results reported in the first quarter 2022, Amgen Inc achieved the best Revenue growth in Biotechnology & Pharmaceuticals industry. While Amgen Inc ' s Revenue no change of % ranks overall at the positon no. in the first quarter 2022.




AMGN Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 2.18 % 8.83 % 274.99 %
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - 2.18 % 8.83 % -1.62 %

Financial Statements
Amgen Inc 's first quarter 2022 Revenue $ 0.00 millions AMGN's Income Statement
Amgen Inc 's first quarter 2021 Revenue $ 0.00 millions Quarterly AMGN's Income Statement
New: More AMGN's historic Revenue Growth >>


AMGN Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - 2.18 % 8.83 % -1.62 %




Revenue first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Amgen Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
14.58 % -4.57 % -100 %
(June 30. 2014)   (Mar 31 2022)


AMGN's I. Quarter Q/Q Revenue Comment
I. Quarter 2022 results of 0.00 millions by Amgen Inc look even worse compare to the 25,979.00 millions a quarter before.

Within Biotechnology & Pharmaceuticals industry 114 other companies have achieved higher Revenue quarter on quarter growth. While Amgen Inc 's Revenue growth quarter on quarter, overall rank is 3136.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #115
Healthcare Sector #552
Overall #3136
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #115
Healthcare Sector #552
Overall #3136
Revenue Q/Q Growth Statistics
High Average Low
14.58 % -4.57 % -100 %
(June 30. 2014)   (Mar 31 2022)


AMGN's I. Quarter Q/Q Revenue Comment
Current accomplishment of 0.00 millions by Amgen Inc look even less good if you take a look at 25,979.00 millions a quarter before.

Within Biotechnology & Pharmaceuticals industry 114 other companies have achieved higher Revenue quarter on quarter growth. While Amgen Inc 's Revenue growth quarter on quarter, overall rank is 3136.


Amgen Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #




Cumulative Revenue growth Comment
In the Mar 31 2022 period, Amgen Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Amgen Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Mar 31 2022 period, Amgen Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Amgen Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
AMGN's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for AMGN's Competitors
Revenue Growth for Amgen Inc 's Suppliers
Revenue Growth for AMGN's Customers

You may also want to know
AMGN's Annual Growth Rates AMGN's Profitability Ratios AMGN's Asset Turnover Ratio AMGN's Dividend Growth
AMGN's Roe AMGN's Valuation Ratios AMGN's Financial Strength Ratios AMGN's Dividend Payout Ratio
AMGN's Roa AMGN's Inventory Turnover Ratio AMGN's Growth Rates AMGN's Dividend Comparisons



Companies with similar Revenue no change for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2022
Hydrofarm Holdings Group Inc -0.01%$ -0.011 millions
Sage Therapeutics Inc -0.06%$ -0.063 millions
Davita Inc -0.09%$ -0.087 millions
Axogen inc -0.10%$ -0.097 millions
Oncternal Therapeutics Inc -0.27%$ -0.267 millions
World Health Energy Holdings Inc.-0.33%$ -0.328 millions
Glaukos Corp-0.42%$ -0.422 millions
Collegium Pharmaceutical inc -0.70%$ -0.699 millions
Tenet Healthcare Corp-0.75%$ -0.753 millions
Nevro Corp -0.87%$ -0.867 millions
Antares Pharma Inc -1.25%$ -1.250 millions
Elanco Animal Health Inc-1.37%$ -1.369 millions
Nanostring Technologies Inc -1.70%$ -1.698 millions
Mimedx Group Inc -1.79%$ -1.789 millions
Exagen Inc -1.82%$ -1.823 millions
Royalty Pharma Plc-1.92%$ -1.916 millions
Veru Inc -2.34%$ -2.339 millions
Delcath Systems Inc -2.58%$ -2.577 millions
Ikena Oncology Inc -2.59%$ -2.591 millions
Therapeuticsmd Inc -2.68%$ -2.683 millions
Ngm Biopharmaceuticals Inc -2.91%$ -2.906 millions
Livanova Plc-3.00%$ -3.000 millions
Lifevantage Corp-3.04%$ -3.037 millions
Reata Pharmaceuticals Inc -3.18%$ -3.178 millions
Bio rad Laboratories Inc -3.68%$ -3.678 millions
Codiak Biosciences Inc -3.69%$ -3.692 millions
Vanda Pharmaceuticals Inc -3.95%$ -3.953 millions
Quest Diagnostics Inc-4.01%$ -4.007 millions
Organogenesis Holdings Inc -4.32%$ -4.325 millions
Myriad Genetics Inc -4.74%$ -4.737 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

DUNE's Profile

Stock Price

DUNE's Financials

Business Description

Fundamentals

Charts & Quotes

DUNE's News

Suppliers

DUNE's Competitors

Customers & Markets

Economic Indicators

DUNE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071